Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Miyatake, Osaka
Kazufumi Miyatake, Osaka JP
| Patent application number | Description | Published |
|---|---|---|
| 20100146304 | EXECUTION DEVICE - A program execution device is a device for executing an application program having at least one class including an execution code created by an object directivity language. The program execution device includes a first execution device having a memory and a processor and a tamper-resistant second execution device having a memory and a processor. When a class is executed, a loader loads an execution code of the class in the memory of the second execution device and loads a portion of the class other than the execution code loaded in the memory of the second execution device, in the memory of the first execution device. | 06-10-2010 |
Kunio Miyatake, Osaka JP
| Patent application number | Description | Published |
|---|---|---|
| 20080317720 | Fat-Derived Progenitor Cell and Use Thereof - An objective of the present invention is to provide methods for producing progenitor cells which show a high proliferation ability ex vivo and promote neovascularization or myocardium regeneration, by culturing pluripotent cells in a medium containing adrenomedullin (AM) and/or vascular endothelial growth factor (VEGF). Moreover, another objective of the present invention is to provide the progenitor cells and uses thereof. In order to solve the above problems, the inventors of the present application have successfully developed a novel culture technique for producing progenitor cells from adipose tissues more efficiently compared to the conventional techniques, by using adrenomedullin (AM) and/or vascular endothelial growth factor (VEGF). The progenitor cells produced by the present inventors are specialized cells having a potent proliferation ability, a revascularization ability, and a myocardium regeneration ability, and have the property of not differentiating into adipocytes even if subjected to differentiation induction into adipocytes. Therefore, the progenitor cells of the present invention can be effective pharmaceutical agents for intractable diseases in the brain, lung, liver, kidney and the like. | 12-25-2008 |
| 20090012499 | NOVEL METHOD FOR TREATING CHRONIC SEVERE HEART FAILURE BY USING INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) - The present invention relates to novel method for treating chronic severe heart failure by using insulin-like growth factor-1 (IGF-1). More specifically, the present invention relates to method for improving cardiovascular function and symptoms in a patient with chronic severe heart failure by administering IGF-1 to the patient for a certain period, wherein no options for treating the disorder the patient remain other than heart transplantation. | 01-08-2009 |
| 20090105171 | Methods for Regenerating and Repairing Damaged Tissues Using Adrenomedullin - [Problems to be Solved] An objective of the present invention is to provide methods for regenerating or repairing damaged tissues using adrenomedullin. Another objective is to provide pharmaceutical agents that comprise adrenomedullin as an active ingredient for regenerating or repairing damaged tissues. | 04-23-2009 |